reference/31670836

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31670836

Outgoing Links

Predicate	Object
contentType	Evaluation Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	137
issn	0014-2999
pageRange	132-137
publicationName	European Journal of Pharmacology
startingPage	132
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_94dc56aa582ec70edd4597d47dd60fb7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c770f7645391956cb6a26af1dc1c8f49 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_29412cf6d04420a1081e76839780c7e0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bbe9cb7bd2221369861fce34782addbf http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d0b0e8cde810acfb42120046086fa54e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_245f9bd48f7d9dcb63172175e1bb24ca http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_02743b5f1bdb53fac673a9f8b7e7e91d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Huang G, Liu X, Jiao L, Xu C, Zhang Z, Wang L, Li Y, Yang C, Zhang W, Sun Y. Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancer. Eur J Pharmacol. 2014 Apr 15;729():132–7. doi: 10.1016/j.ejphar.2014.01.048. PMID: 24556387.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fee8ca4cee62c8fc5bda2af335d20a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4b495dbabdac29b5f1fa76c683fa867 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2433-6823 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e60cf31e08b2d72ec2140392df2324b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8b85ccd860354c5b7bc7db912483076 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c2fdc6386ead759c7bc02d55dace3a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce7b140cf20ae0ecc1bb014dc2164a4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80517fcb611598b937ec385481283486 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2df26c6b874eab63f1b2372157dd3408 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e41830cbc508e8e52d23a035c0350fb8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_977cbb0062fd86fba4ad3e3566506456
date	2014-04-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/24556387 https://doi.org/10.1016/j.ejphar.2014.01.048
isPartOf	https://portal.issn.org/resource/ISSN/0014-2999 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3614
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Metabolomic evaluation of the response to endocrine therapy in patients with prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0010537 http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000097 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D006727Q000627 http://id.nlm.nih.gov/mesh/D055432Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D014408Q000097 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011471Q000175 http://id.nlm.nih.gov/mesh/D011897 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65091 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8066 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12544 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105068 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105069 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497182 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528

Showing number of triples: 1 to 60 of 60.